Evidence map›Paper›PMID 35095546›Full record

ReviewFrontiers in physiology2021

Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems.

Yashvardhan Batta, Cody King, John Johnson, Natasha Haddad, Myriam Boueri, Georges Haddad

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yashvardhan BattaDepartment Physiology and Biophysics, College of Medicine, Howard University, Washington, DC, United States.
Cody KingDepartment Physiology and Biophysics, College of Medicine, Howard University, Washington, DC, United States.
John JohnsonDepartment Physiology and Biophysics, College of Medicine, Howard University, Washington, DC, United States.
Natasha HaddadDepartment Physiology and Biophysics, College of Medicine, Howard University, Washington, DC, United States.
Myriam BoueriLebanese American University, Beirut, Lebanon.
Georges HaddadDepartment Physiology and Biophysics, College of Medicine, Howard University, Washington, DC, United States.
Howard University · USLebanese American University · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 patients with pre-existing cardiovascular conditions are at greater risk of severe illness due to the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus. This review evaluates the highest risk factors for these patients, not limited to pre-existing hypertension, cardiac arrhythmias, hypercoagulation, ischemic heart disease, and a history of underlying heart conditions. SARS-CoV-2 may also precipitate

Indexed as

agingcardiac arrhythmiasCOVID-19hypercoagulationhypertensionischemic heart diseaseneuropathySARS-CoV-2

Identifiers

PMID35095546
PMCPMC8795698
OpenAlexW4205964396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.